EyePoint Pharmaceuticals, Inc. — Director's Dealing 2014

May 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2014-05-05

Reporting Person: Freedman Lori (VP Corp. Affairs, GC and Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-05	Common Stock	M	3500	$1.81	Acquired	99923	Direct
2014-05-05	Common Stock	S	3500	$4.01	Disposed	96423	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-05	Stock Option (Right to Buy)	$1.81	M	3500	Disposed	2019-06-25	Common Stock (3500)	Direct

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.

F2: The option was granted on 06/25/2009 and vested in four equal annual installments beginning on the first anniversary of the date of grant.